Clinical outcome of biodegradable polymer sirolimus-eluting stent and durable polymer everolimus-eluting stent in patients with diabetes

BACKGROUND: Diabetes mellitus is a risk for increased incidence of adverse clinical events after percutaneous coronary intervention. However, the difference in the incidence of adverse clinical events according to stent type in patients with diabetes remains to be elucidated. In the present study, w...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Cardiovasc Diabetol
Prif Awduron: Kakizaki, Ryota, Minami, Yoshiyasu, Katamine, Masahiro, Katsura, Aritomo, Muramatsu, Yusuke, Hashimoto, Takuya, Meguro, Kentaro, Shimohama, Takao, Ako, Junya
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: BioMed Central 2020
Pynciau:
Original Investigation
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7531093/
https://ncbi.nlm.nih.gov/pubmed/33004019
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12933-020-01145-x
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg